Search

Lu Wang

from Malden, MA
Age ~37
Get Report
Related to:
Ying Wang, 56Junyong Wang, 48Lianrong Wang, 45
Connected to:
Adele R Wang, 107Aiyuan Wang, 52Akiet Wang, 74Alene P Wang, 52Amanda K Wang, 46Amei Wang, 61Amity H Wang, 70Amy Wang, 59Anastasia S Wang, 85Ange Wang, 35

Lu Wang Phones & Addresses

  • Malden, MA
  • Binghamton, NY

Professional Records

License Records

Lu Wang

License #:
31703 - Active
Issued Date:
Dec 13, 2013
Renew Date:
Dec 1, 2015
Expiration Date:
Nov 30, 2017
Type:
Certified Public Accountant

Lu Wang

License #:
111323 - Expired
Category:
Nursing Support
Issued Date:
Oct 31, 2013
Effective Date:
Oct 31, 2013
Type:
Nurse Aide

Medicine Doctors

Lu Wang Photo 1

Lu Wang

View page
Specialties:
Clinical Molecular Genetics
Clinical Cytogenetic

Resumes

Resumes

Lu Wang Photo 2

Lu Wang Allston, MA

View page
Work:
PricewaterhouseCoopers

Nov 2012 to 2000
Associate
Babson College
Babson Park, MA
Apr 2009 to May 2012
Research and Program Assistant
Nielsen

May 2011 to Jul 2011
Intern Nielsen Online Products
Putnam Investments
Boston, MA
Jun 2010 to Aug 2010
Summer Intern
QQ Bakery
Flushing, NY
Nov 2005 to Jul 2008
Customer Service Representative
Abercrombie & Fitch
Garden City, NY
Oct 2007 to May 2008
Store Clerk (Impact Team)
Queens Public Library
Jackson Heights, NY
Oct 2006 to Mar 2007
Library Assistant
Education:
Babson College
Babson Park, MA
2012 to 2013
Master in science of accounting in Accounting
Babson College
Babson Park, MA
2008 to 2012
Bachelor in Business Administration in Accounting
Skills:
1. Fluent in Mandarin and English,2. Proficient in Microsoft Word, Excel, PowerPoint, Access, Accounting, OneNote, Millennium. 3. Knowledge of operating stock and pricing system.
Lu Wang Photo 3

Lu Wang Somerville, MA

View page
Work:
Ivy Experience Tours

Dec 2011 to Present
Manager and Founder
Harvard Department of Evolutionary Biology

Aug 2010 to May 2012
Researcher
Teach For America
Phoenix, AZ
Mar 2011 to Aug 2011
Operations Coordinator at the Phoenix institute
Ivy Insiders
Cambridge, MA
Mar 2009 to Aug 2010
Branch Manager and Regional Manager
Harvard Ballroom Dance Team
Cambridge, MA
Mar 2009 to Mar 2010
President
Education:
Harvard University
Cambridge, MA
May 2012
B.A. in Economics, Biology
Skills:
programming in C, HTML, STATA, MS Excel, PowerPoint, and Outlook.
Lu Wang Photo 4

Lu Wang Austin, TX

View page
Work:
WATERS CORPORATION
Milford, MA
Jun 2011 to Dec 2011
MBA Intern, Worldwide Marketing Department
RC2 CORPORATION (Subsidiary of TOMY)
Boston, MA
Sep 2010 to May 2011
Part-time Consultant, Babson Consulting Alliance Program
EAST KIT ELECTRONIC LTD

2008 to 2010
Sales Marketing Manager
YOU YANG ADVERTISING LTD

2006 to 2007
Editor, managed dining column of two popular newspapers
Education:
BABSON COLLEGE, F.W. OLIN GRADUATE SCHOOL OF BUSINESS
Boston, MA
2010 to 2012
Master of Business Administration
Shanghai University
2002 to 2006
BA in Advertisement
Skills:
Business Development Negotiation Contracts and Agreements on International Business Rapport and Cooperative Customer Alliance and Partnership Building Cross-functional Team Leadership Market Intelligence Marketing Research Marketing Campaign Development and Implementation Strategic Planning Fluent in English, Chinese Mandarin, Chinese Shanghainese
Lu Wang Photo 5

Lu Wang

View page

Publications

Us Patents

Novel Tricyclic Compounds

View page
US Patent:
20230082167, Mar 16, 2023
Filed:
Jan 14, 2022
Appl. No.:
17/575731
Inventors:
- North Chicago IL, US
Maria A. ARGIRIADI - Wayland MA, US
David J. CALDERWOOD - Framingham MA, US
Anna M. Ericsson - Shrewsbury MA, US
Bryan A. FIAMENGO - Worcester MA, US
Kristine E. FRANK - Grayslake IL, US
Michael M. FRIEDMAN - Brookline MA, US
Dawn M. GEORGE - Charlton MA, US
Eric R. GOEDKEN - Worcester MA, US
Nathan S. JOSEPHSOHN - Cambridge MA, US
Biqin C. LI - Southborough MA, US
Michael J. MORYTKO - Framingham MA, US
Kent D. STEWART - Gurnee IL, US
Jeffrey W. VOSS - Holden MA, US
Grier A. WALLACE - Sterling MA, US
Lu WANG - Northborough MA, US
Kevin R. WOLLER - Antioch IL, US
International Classification:
C07D 487/14
C07D 498/14
C07D 513/14
Abstract:
The invention provides a compound of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.

Multi-Termination Scheme Interface

View page
US Patent:
20210305983, Sep 30, 2021
Filed:
Jun 11, 2021
Appl. No.:
17/345984
Inventors:
- Singapore, SG
Lu Wang - Framingham MA, US
International Classification:
H03K 19/00
H03K 19/20
Abstract:
In an embodiment, a method includes programming a control signal that specifies a target resistance and a target voltage in a circuit. The method further includes sending the control signal to at least one transistor configured to control a current flow in the circuit. The method further includes providing, as an output, a signal with the target voltage and target resistance.

Novel Tricyclic Compounds

View page
US Patent:
20210061813, Mar 4, 2021
Filed:
Jun 13, 2019
Appl. No.:
16/440442
Inventors:
- North Chicago IL, US
Maria A. ARGIRIADI - Southborough MA, US
David J. CALDERWOOD - Framingham MA, US
Anna M. ERICSSON - Shrewsbury MA, US
Bryan A. FIAMENGO - Anaheim CA, US
Kristine E. FRANK - Grayslake IL, US
Michael M. FRIEDMAN - Kennebunkport ME, US
Dawn M. GEORGE - Lancaster MA, US
Eric R. GOEDKEN - Worcester MA, US
Nathan S. JOSEPHSOHN - Cambridge MA, US
Biqin C. LI - Naples FL, US
Michael J. MORYTKO - Westborough MA, US
Kent D. STEWART - Charlotte NC, US
Jeffrey W. VOSS - Holden MA, US
Grier A. WALLACE - Sterling MA, US
Lu WANG - Northborough MA, US
Kevin R. WOLLER - Antioch IL, US
Assignee:
AbbVie Inc. - North Chicago IL
International Classification:
C07D 487/14
A61K 45/06
A61K 31/4985
A61K 31/437
C07D 471/14
C07D 498/14
C07D 513/14
Abstract:
The invention provides compounds of Formula (I) and Formula (II)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.

Baseline Wander Compensation

View page
US Patent:
20190103875, Apr 4, 2019
Filed:
Sep 29, 2017
Appl. No.:
15/719973
Inventors:
- Santa Clara CA, US
Lu Wang - Framingham MA, US
International Classification:
H03L 7/08
H03L 5/00
H04L 7/00
H04L 7/04
H04L 25/03
Abstract:
A data recovery circuit provides compensation for baseline wander exhibited by a data signal. An adaptive equalizer generates a recovered data signal from a data input. A level shifter and low-pass filter provide a compensation signal as a function of the recovered data signal. An adaptation engine adjusts the level of the compensation signal to compensate for baseline wander. The adaptive equalizer generates the recovered data signal as a function of the data input and the compensation signal, thereby providing accurate recovery of the data signal.

Novel Tricyclic Compounds

View page
US Patent:
20180291029, Oct 11, 2018
Filed:
Nov 7, 2017
Appl. No.:
15/806104
Inventors:
- North Chicago IL, US
Maria A. Argiriadi - Wayland MA, US
David J. Calderwood - Framingham MA, US
Anna M. Ericsson - Shrewsbury MA, US
Bryan R. Fiamengo - Worcester MA, US
Kristine E. Frank - Grayslake IL, US
Michael M. Friedman - Brookline MA, US
Dawn M. George - Charlton MA, US
Eric R. Goedken - Worcester MA, US
Nathan S. Josephsohn - Cambridge MA, US
Biqin C. Li - Southborough MA, US
Michael J. Morytko - Framingham MA, US
Kent D. Stewart - Gurnee IL, US
Jeffrey W. Voss - Holden MA, US
Grier A. Wallace - Sterling MA, US
Lu Wang - Northborough MA, US
Kevin R. Woller - Antioch IL, US
Assignee:
AbbVie Inc. - North Chicago IL
International Classification:
C07D 487/14
C07D 513/14
C07D 498/14
Abstract:
The invention provides a compound of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.

Novel Tricyclic Compounds

View page
US Patent:
20160326181, Nov 10, 2016
Filed:
May 12, 2016
Appl. No.:
15/152823
Inventors:
- North Chicago IL, US
Maria A. Argiriadi - Wayland MA, US
David J. Calderwood - Framingham MA, US
Anna M. Ericsson - Shrewsbury MA, US
Bryan R. Fiamengo - Worcester MA, US
Kristine E. Frank - Grayslake IL, US
Michael M. Friedman - Brookline MA, US
Dawn M. George - Charlton MA, US
Eric R. Goedken - Worcester MA, US
Nathan S. Josephsohn - Cambridge MA, US
Biqin C. Li - Southborough MA, US
Michael J. Morytko - Framingham MA, US
Kent D. Stewart - Gurnee IL, US
Jeffrey W. Voss - Holden MA, US
Grier A. Wallace - Sterling MA, US
Lu Wang - Northborough MA, US
Kevin R. Woller - Antioch IL, US
Assignee:
AbbVie Inc. - North Chicago IL
International Classification:
C07D 487/14
Abstract:
The invention provides a compound of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.

Novel Tricyclic Compounds

View page
US Patent:
20160222020, Aug 4, 2016
Filed:
Feb 8, 2016
Appl. No.:
15/017802
Inventors:
- North Chicago IL, US
Maria A. Argiriadi - Wayland MA, US
David J. Calderwood - Framingham MA, US
Anna M. Ericsson - Shrewsbury MA, US
Bryan A. Fiamengo - Worcester MA, US
Kristine E. Frank - Grayslake IL, US
Michael M. Friedman - Brookline MA, US
Dawn M. George - Charlton MA, US
Eric R. Goedken - Worcester MA, US
Nathan S. Josephsohn - Cambridge MA, US
Biqin C. Li - Southborough MA, US
Michael J. Morytko - Framingham MA, US
Kent D. Stewart - Gurnee IL, US
Jeffrey W. Voss - Holden MA, US
Grier A. Wallace - Sterling MA, US
Lu Wang - Northborough MA, US
Kevin R. Woller - Antioch IL, US
Assignee:
AbbVie Inc. - North Chicago IL
International Classification:
C07D 487/14
A61K 31/437
C07D 471/14
A61K 31/4985
A61K 45/06
Abstract:
The invention provides compounds of Formula (I) and Formula (II)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.

Novel Tricyclic Compounds

View page
US Patent:
20150210708, Jul 30, 2015
Filed:
Jan 30, 2015
Appl. No.:
14/610119
Inventors:
- North Chicago IL, US
Maria A. Argiriadi - Wayland MA, US
David J. Calderwood - Framingham MA, US
Anna M. Ericsson - Shrewsbury MA, US
Bryan A. Fiamengo - Worcester MA, US
Kristine E. Frank - Grayslake IL, US
Michael M. Friedman - Brookline MA, US
Dawn M. George - Charlton MA, US
Eric R. Goedken - Worcester MA, US
Nathan S. Josephsohn - Boston MA, US
Biqin C. Li - Southborough MA, US
Michael J. Morytko - Framingham MA, US
Kent D. Stewart - Gurnee IL, US
Jeffrey W. Voss - Holden MA, US
Grier A. Wallace - Sterling MA, US
Lu Wang - Northborough MA, US
Kevin R. Woller - Antioch IL, US
Assignee:
AbbVie Inc. - North Chicago IL
International Classification:
C07D 487/14
Abstract:
The invention provides a compound of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Control profile
Lu Wang from Malden, MA, age ~37 Get Report